Tom Baker Cancer Centre-Calgary; Clinical Research Unit
Calgary, Alberta, Canada
Cancer treatment center in Calgary, Alberta
1331 29 St NW, Calgary, AB T2N 4N2
About Tom Baker Cancer Centre-Calgary; Clinical Research Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Tom Baker Cancer Centre-Calgary; Clinical Research Unit
During the past decade, Tom Baker Cancer Centre-Calgary; Clinical Research Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)
2016-01-25
2017-07-12
Completed
10
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
2016-06-30
2023-06-30
Active, not recruiting
1,214
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Tom Baker Cancer Centre-Calgary; Clinical Research Unit
According to Clinical.Site data, the most researched conditions in "Tom Baker Cancer Centre-Calgary; Clinical Research Unit" are
"Myelofibrosis" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Tom Baker Cancer Centre-Calgary; Clinical Research Unit" in a lesser frequency.
Clinical Trials Intervention Types at Tom Baker Cancer Centre-Calgary; Clinical Research Unit
Most popular intervention types in "Tom Baker Cancer Centre-Calgary; Clinical Research Unit" are "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Atezolizumab" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tom Baker Cancer Centre-Calgary; Clinical Research Unit
The vast majority of trials in "Tom Baker Cancer Centre-Calgary; Clinical Research Unit" are
2 trials for "All" genders.
Clinical Trials Status at Tom Baker Cancer Centre-Calgary; Clinical Research Unit
Currently, there are NaN active trials in "Tom Baker Cancer Centre-Calgary; Clinical Research Unit".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Tom Baker Cancer Centre-Calgary; Clinical Research Unit,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tom Baker Cancer Centre-Calgary; Clinical Research Unit, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".